Estadísticas
Número total de visitas
| Visualizaciones | |
|---|---|
| Heterologous Systemic Prime–Intranasal Boosting Using a Spore SARS-CoV-2 Vaccine Confers Mucosal Immunity and Cross-Reactive Antibodies in Mice as well as Protection in Hamsters | 266 |
Visitas al mes
| diciembre 2025 | enero 2026 | febrero 2026 | marzo 2026 | abril 2026 | mayo 2026 | junio 2026 | |
|---|---|---|---|---|---|---|---|
| Heterologous Systemic Prime–Intranasal Boosting Using a Spore SARS-CoV-2 Vaccine Confers Mucosal Immunity and Cross-Reactive Antibodies in Mice as well as Protection in Hamsters | 7 | 29 | 11 | 8 | 8 | 8 | 0 |
Visitas al fichero
| Visualizaciones | |
|---|---|
| Katsande_Heterologous_2022.pdf | 3 |
Países con más visualizaciones
| Visualizaciones | |
|---|---|
| Estados Unidos | 69 |
| Singapur | 49 |
| Irlanda | 19 |
| China | 14 |
| Vietnam | 13 |
| Brasil | 9 |
| España | 9 |
| Suecia | 9 |
| Alemania | 3 |
| India | 3 |
Ciudades con más visualizaciones
| Visualizaciones | |
|---|---|
| Singapore | 34 |
| Boardman | 24 |
| Dublin | 19 |
| Ashburn | 15 |
| Hanoi | 9 |
| Beijing | 5 |
| Roquetes | 4 |
| Council Bluffs | 3 |
| Pune | 3 |
| Barcelona | 2 |